Cefazolin sodium and Hypocalcaemia - a phase IV clinical study of FDA data

Summary:

Hypocalcaemia is reported as a side effect among people who take Cefazolin sodium (cefazolin sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Revlimid, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Hypocalcaemia when taking Cefazolin sodium. It is created by eHealthMe based on reports of 3,643 people who have side effects when taking Cefazolin sodium from the FDA, and is updated regularly.

What is Cefazolin sodium?

Cefazolin sodium has active ingredients of cefazolin sodium. eHealthMe is studying from 3,649 Cefazolin sodium users. Check the latest studies of Cefazolin sodium.

What is Hypocalcaemia?

Hypocalcaemia (levels of calcium in blood serum are abnormally low) is found to be associated with 1,204 drugs and 1,302 conditions by eHealthMe. Check the latest studies of Hypocalcaemia.

On Jul, 19, 2026

3,643 people reported to have side effects when taking Cefazolin sodium.
Among them, 27 people (0.74%) have Hypocalcaemia.

Could Cefazolin sodium cause Hypocalcaemia?

Among these 27 people:

How long have people been on Cefazolin sodium when they have Hypocalcaemia? *

What is the gender of people who have Hypocalcaemia when taking Cefazolin sodium? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Hypocalcaemia when taking Cefazolin sodium? *

What are other drugs people take besides Cefazolin sodium? *

What are other side effects people have besides Hypocalcaemia? *

Anaemia (lack of blood): 17 people, 62.96%
Thrombocytopenia (decrease of platelets in blood): 17 people, 62.96%
Pneumonia: 15 people, 55.56%
High Blood Pressure: 14 people, 51.85%
Oedema Peripheral (superficial swelling): 14 people, 51.85%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 13 people, 48.15%
Essential Thrombocythaemia (chronic blood cancer): 12 people, 44.44%
Dehydration (dryness resulting from the removal of water): 12 people, 44.44%
Depression: 12 people, 44.44%
Diastolic Dysfunction: 12 people, 44.44%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 9 people, 33.33%
Bone Disorder: 6 people, 22.22%
Adverse Event: 3 people, 11.11%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 11.11%
Joint Pain: 3 people, 11.11%
High Blood Pressure: 3 people, 11.11%
Hyperparathyroidism Primary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium- primary): 2 people, 7.41%
Cancer Pain: 2 people, 7.41%
Cardiac Failure Chronic: 2 people, 7.41%
Coagulation Test Abnormal: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin sodium and have Hypocalcaemia?

- Check whether Hypocalcaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefazolin sodium:

Cefazolin sodium (3,649 reports)

Hypocalcaemia treatments and more:

Hypocalcaemia (26,346 reports)

Browse all side effects of Cefazolin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypocalcaemia:

Hypocalcaemia (1,204 drugs)

Browse all the conditions that are associated with Hypocalcaemia:

Hypocalcaemia (1,302 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium (the active ingredients of Cefazolin sodium) and Cefazolin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.